Substance / Medication

Digoxin immune fab

Overview

Active Ingredient
digoxin antibodies Fab fragments
RxNorm CUI
203223

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Digoxin immune fab treatment for severe preeclampsia.
Adair C David, Buckalew Vardaman M, Graves Steven W et al. · Am J Perinatol · 2010
PMID: 20232280RCT
Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.
DiDomenico R J, Walton S M, Sanoski C A et al. · J Cardiovasc Pharmacol Ther · 2000
PMID: 11150387Observational
Should digoxin immune fab be administered based solely on reported ingested amount in acute digoxin poisoning?
Cole Jon B, Pepin Lesley C, Oakland Carrie L et al. · Am J Emerg Med · 2025
PMID: 39848856Case Report
Characterizing Utilization and Outcomes of Digoxin Immune Fab for Digoxin Toxicity.
Sheikh Sophia, Munson Taylor, Garvan Gerard et al. · Drugs Real World Outcomes · 2024
PMID: 38839728OtherFull text (PMC)
Digoxin immune fab protects endothelial cells from ouabain-induced barrier injury.
Wang Yuping, Fan Ruping, Gu Yang et al. · Am J Reprod Immunol · 2012
PMID: 21749548OtherFull text (PMC)
Treatment of chronically digoxin-poisoned patients with a newer digoxin immune fab--a retrospective study.
Schaeffer Tammi H, Mlynarchek Sara L, Stanford Christopher F et al. · J Am Osteopath Assoc · 2010
PMID: 21068223Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Digoxin immune fab (substance)
SNOMED CT
68332000
UMLS CUI
C0700607
RxNorm CUI
203223

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.